Deciphering the cause of Friedreich ataxia

Current Opinion in Neurobiology

Volumn 7, Issue 5, 1997, Pages 689-694

  Kœnig, Michel ^a   Mandel, Jean Louis ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FREE RADICAL; IRON; MITOCHONDRIAL DNA;

ALPHA TOCOPHEROL DEFICIENCY; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 9; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXON; FRIEDREICH ATAXIA; GENE EXPRESSION REGULATION; GENE MUTATION; GENE STRUCTURE; GRAM NEGATIVE BACTERIUM; HUMAN; INTRON; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; YEAST;

EID: 0342813045     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(97)80090-6     Document Type: Article

References (52)

1. Leone M, Brignolio F, Rosso MG, Curtoni ES, Moroni A, Tribolo A, Schiffer D: Friedreich's ataxia: a descriptive epidemiological study in an Italian population. Clin Genet 1990, 38:161-169.
2. Cossée M, Schmitt M, Campuzano V, Reutenauer L, Moutou C, Mandel J-L, Koenig M: Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci USA 1997, 94:7452-7457. The origin of the Friedreich ataxia GAA expansion mutations in the European population is traced down by linkage disequilibrium analysis. The frequency of heterozygote carriers of expansion is directly estimated from the study of 851 individuals.
3. Geoffroy G, Barbeau A, Breton G, Lemieux B, Aube M, Leger C, Bouchard JP: Clinical description and roentgenologic evaluation of patients with Friedreich ataxia. Can J Neurol Sci 1976, 3:279-286.
4. Harding AE: Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnosis criteria and intrafamilial clustering of clinical features. Brain 1981, 104:589-620.
5. Oppenheimer DR, Esiri MM: Disease of the basal ganglia, cerebellum and motor neurons. In Greenfield's Neuropathology, edn 5. Edited by Adams JH, Corsellis JAN, Duchen LW. London: Arnold; 1992:1015-1018.
6. Cedarbaum JM, Blass JP: Mitochondrial dysfunction and spinocerebellar degenerations. Neurochem Pathol 1986, 4:43-63.
7. Chamberlain S, Shaw J, Rowland A, Wallis J, South S, Nakamura Y, von Gabain A, Farrall M, Williamson R: Mapping of mutation causing Friedreich ataxia to human chromosome 9. Nature 1988, 334:248-250.
8. Fujita R, Agid Y, Trouillas P, Seek A, Tommasi-Davenas C, Driesel AJ, Olek K, Grzeschik KH, Nakamura Y, Mandel JL et al.: Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker. Genomics 1989, 4:110-111.
9. Hanauer A, Chery M, Fujita R, Driesel AJ, Gilgenkrantz S, Mandel JL: The Friedreich ataxia gene is assigned to chromosome 9q13- q21 by mapping of tightly linked markers, and shows linkage disequilibrium with D9S15. Am J Hum Genet 1990, 46:133-137.
10. Keats BJB, Ward LJ, Shaw J, Wickremasinghe A, Chamberlain S: "Acadian" and "classical" forms of Friedreich ataxia are most probable caused by mutations at the same locus. Am J Med Genet 1989, 33:266-268.
11. Chamberlain S, Shaw J, Wallis J, Rowland A, Chow L, Farral M, Keats B, Richter A, Roy M, Melanion S et al.: Genetic homogeneity at the Friedreich ataxia locus on chromosome 9. Am J Hum Genet 1989, 44:518-521.
12. Fujita R, Hanauer A, Sirugo G, Heilig R, Mandel JL: Additional polymorphisms at marker loci D9S5 and D9S15 generate extended haplotypes in linkage disequilibrium with Friedreich ataxia. Proc Natl Acad Sci USA 1990, 87:1796-1800.
13. Pandolfo M, Sirugo G, Antonelli A, Weitnauer L, Ferreti L, Leone M, Dones I, Cerino A, Fujita R, Hanauer A et al.: Friedreich ataxia in Italian families: genetic homogeneity and linkage disequilibrium with the marker loci D9S5 and D9S15. Am J Hum Genet 1990, 47:228-235.
14. Rodius F, Duclos F, Wrogemann K, Le Paslier D, Ougen P, Billault A, Belal S, Musenger C, Brice A, Dürr A et al.: Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval. Am J Hum Genet 1994, 54:1050-1059.
15. Montermini L, Rodius F, Pianese L, Molt MD, Cessée M, Campuzano V, Cavalcanti F, Monticelli A, Paiau F, Gyapay G et al.: The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13. Am J Hum Genet 1995, 57:1061-1067.
16. Duclos F, Boschert U, Sirugo G, Mandel J-L, Hen R, Koenig M: Gene in the region of the Friedreich ataxia locus encodes a putative transmembrane protein expressed in the nervous system. Proc Natl Acad Sci USA 1993, 90:109-113.
17. Duclos F, Rodius F, Wrogemann K, Mandel J-L, Koenig M: The Friedreich ataxia region: characterization of two novel genes and reduction of the critical region to 300 kb. Hum Mol Genet 1994, 3:909-914.
18. Carvajal J, Pook MA, Doudney K, Hillermann R, Wilkes D, Al-Mahdawi S, Williamson R, Chamberlain S: Friedreich ataxia: a defect in signal transduction? Hum Mol Genet 1995, 4:1411-1419.
19. Campuzano V, Montermini L, Molt MD, Pianese L, Cossé M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A et al.: Friedreich ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427. The discovery of an intronic GAA expansion as the major cause of Friedreich ataxia was surprising in many regards as the position, sequence and mode of inheritance of the expansion mutation were different from other expansion diseases. The identified gene encoded a novel protein that is conserved through evolution.
20. Paulson HL, Fischbeck KH: Trinucleotide repeats in neurogenetic disorders. Annu Rev Neurosci 1996, 19:79-107.
21. Carvajal J, Pook MA, dos Santos M, Doudney K, Hillermann R, Minogue S, Williamson R, Hsuan JJ, Chamberlain S: The Friedreich's ataxia gene encodes a novel phophatidylinositol-4-phosphate 5-kinase. Nat Genet 1996, 14:157-162.
22. Koutnikova H, Campuzano V, Foury F, Dollé P, Cazzalini O, Koenig M: Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997, 16:345-351. A mitochondrial role for frataxin is indicated by its high expression in mitochondrial-rich tissues in mouse, the mitochondrial localisation of human frataxin and the mitochondria-deficient phenotype of the yeast frataxin knock-out.
23. Cossée M, Campuzano V, Koutnikova H, Fischbeck KH, Mandel J-L, Koenig M, Bidichandani S, Patel PI, Molt MD, Caizares J et al.: Frataxin fracas. Nat Genet 1997, 15:337-338.
24. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P et al.: Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997, 6:1771-1780. Direct demonstration of frataxin localisation to mitochondrial membranes and alteration in patients (as measured by specific monoclonal antibodies).
25. Bidichandani S, Ashizawa T, Patel PI: Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet 1997, 60:1251-1256.
26. Dürr A, Cossée M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel J-L, Brice A, Koenig M: Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 1996, 335:1169-1175. See annotation [28•].
27. Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, Cocozza S: The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996, 59:554-560. See annotation [28•].
28. Montermini L, Richter A, Morgan K, Justice CM, Julien D, Castelloti B, Mercier J, Poirier J, Capazzoli F, Bouchard JP et al.: Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol 1997, 41:675-682. These three studies [26•-28•] present clinical definitions of Friedreich ataxia revisited in the light of molecular criteria.
29. Monros E, Molt MD, Martinez F, Caizares J, Blanca J, Vilchez JJ, Prieto F, de Frutos R, Palau F: Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet 1997, 61:101-110.
30. Lamont PJ, Davis MB, Wood NW: Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients. Clinical and genetic correlates. Brain 1997, 120:673-680.
31. Isnard R, Kalotka H, Dürr A, Cossée M, Schmitt M, Pousset F, Thomas D, Brice A, Koenig M, Komajda M: Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia. Circulation 1997, 95:2247-2249.
32. Epplen C, Epplen JT, Frank G, Miterski B, Santos EJM, Schöls L: Differential stability of the (GAA)n tract in the Friedreich ataxia gene. Hum Genet 1997, 99:834-836.
33. Montermini L, Andermann E, Richter A, Pandolfo M, Cavalcanti F, Pianese L, Iodice L, Farina G, Monticelli A, Turano M et al.: The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum Mol Genet 1997, 6:1261-1266.
34. Imbert G, Kretz C, Johnson K, Mandel J-L: Origin of the expansion mutation in myotonic dystrophy. Nat Genet 1993, 4:72-76.
35. Gibson TJ, Koonin EV, Musco G, Pastore A, Bork P: Friedreich's ataxia protein: bacterial homologs point to mitochondrial dysfunction. Trends Neurosci 1996, 19:465-468. A phylogenetic hint that the frataxin gene derives from the genome of the bacterial endosymbiotic precursor of mitochondria.
36. Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J: Regulation of mitochondrial iron accumulation by Yfh1, a putative homolog of frataxin. Science 1997, 276:1709-1712. See annotation [38••].
37. Wilson RB, Roof DM: Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet 1997, 16:352-357. See annotation [38••].
38. Foury F, Cazzalini O: Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett 1997, 411:373-377. In these three papers [36••,37•,38;••], the authors demonstrate the involvement of yeast frataxin in iron homeostasis both from the phenotype of the corresponding knock-out and from high copy suppression of another mutant showing slow growth on iron-poor medium. The results suggest that oxidative stress is the primary pathological mechanism in Friedreich ataxia.
39. Lamarche JB, Shapcott D, Côté M, Lemieux B: Cardiac iron deposits in Friedreich's ataxia. In Handbook of Cerebellar Diseases, edn 1. Edited by Lechtenberg R. New York: Marcel Dekker; 1993:453-458.
40. Rötig A, deLonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P: Frataxin gene expansion causes aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat Genet 1997, 17:215-217. Demonstration of a selective and generalized Fe-S protein deficiency restricted to affected tissues of Friedreich ataxia patients.
41. Fridovitch I: Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995, 64:97-112.
42. Kaptain S, Downey WE, Tang C, Philpott C, Haile D, Orloff DG, Harford JB, Rouault TA, Klausner RD: A regulated RNA binding protein also possesses aconitase activity. Proc Natl Acad Sci USA 1991, 88:10109-10113.
43. Ben Hamida M, Belal S, Sirugo G, Ben Hamida C, Panayides K, Ioannou P, Beckmann J, Mandel J-L, Hentati F, Koenig M, Middleton L: Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology 1993, 43:2179-2183.
44. Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, Gyapay G, Vignal A, Le Paslier D, Cohen D et al.: Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet 1993, 5:195-200.
45. Doerflinger N, Linder C, Ouahchi K, Gyapay G, Weissenbach J, Le Paslier D, Rigault P, Belal S, Ben Hamida C, Hentati F et al.: Ataxia with vitamin E deficiency: refinement of genetic localisation and analysis of linkage disequilibrium using new markers in 14 families. Am J Hum Genet 1995, 56:1116-1124.
46. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ: Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest 1990, 85:397-407.
47. Sato Y, Arai H, Miyata A, Tokita S, Yamamoto K, Tanabe T, Inoue K: Primary structure of alpha-tocopherol transfer protein from rat liver. J Biol Chem 1993, 268:17705-17710.
48. Arita M, Sato Y, Miyata A, Tanabe T, Takahashi E, Kayden HJ, Arai H, Inoue K: Human α-tocopherol transfer protein: cDNA cloning, expression and chromosomal localisation. Biochem J 1995, 306:437-443.
49. Ouahchi K, Arita M, Kayden HJ, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel J-L, Koenig M: Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nat Genet 1995, 9:141-145.
50. Gotoda T, Arita M, Arai H, Inoue K, Yokota T, Fukuo Y, Yazaki Y, Yamada N: Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for α-tocopherol transfer protein. N Engl J Med 1995, 333:1313-1318.
51. Hentati A, Deng HX, Hung WY, Nayer M, Ahmed MS, He X, Tim R, Stumpf DA, Siddique T: Human α-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency. Neurology 1996, 39:295-300.
52. Di Mascio P, Murphy ME, Sies H: Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 1991, 53:194S-200S.